Florastor Dosing with Antibiotic Use
For adults taking antibiotics, administer Saccharomyces boulardii (Florastor) 250-500 mg twice daily, starting within 24-48 hours of antibiotic initiation, continuing throughout the entire antibiotic course, and extending for 7 days after antibiotic completion.
Dosing Regimen
Standard Adult Dose
- Dose: 250-500 mg (or 5-10 billion CFU) twice daily
- Timing relative to antibiotics: Start within 24-48 hours of first antibiotic dose 1, 2
- Duration: Continue throughout entire antibiotic course PLUS 7 additional days after antibiotics stop 3, 4, 2
Timing Considerations
The evidence strongly supports early initiation. Patients who received S. boulardii within 24 hours of antibiotic start had significantly lower risk of hospital-onset C. difficile infection (OR 0.47) compared to those who started after 24 hours 1. This represents a critical window—don't delay initiation.
Relationship to Antibiotic Doses
S. boulardii is a yeast, not a bacterium, so it is not affected by antibiotics 2. Therefore, you can administer it at the same time as antibiotics without concern for reduced efficacy. No separation between doses is required.
Evidence Quality and Strength
The recommendation is based on multiple high-quality studies showing:
- Prevention of antibiotic-associated diarrhea: S. boulardii reduced AAD incidence from 28-30% to 13.3-14.8% in hospitalized patients 5, 6
- C. difficile prevention: 48-52% risk reduction for healthcare facility-onset CDI when administered with high-risk antibiotics 1, 7
- Microbiota recovery: Enhanced return to baseline bacterial populations after antibiotic completion 8
The European guideline data 3 specifically evaluated S. boulardii at 2×10^10 CFU/day (approximately 1000 mg/day) for 4 weeks following vancomycin 500 mg four times daily, showing significant reduction in C. difficile recurrence (17% vs 50%, p=0.05).
High-Risk Scenarios Warranting Prophylaxis
Target S. boulardii prophylaxis particularly for:
- Ceftriaxone use: 76% risk reduction for CDI (NNT=100) 7
- Pneumonia treatment: 57% risk reduction for CDI 7
- Fluoroquinolones, clindamycin, or broad-spectrum penicillins: All high-risk antibiotics for CDI
- Elderly patients (>65 years): Higher baseline AAD risk 6
Pediatric Dosing
For children ≥4 years: 250 mg (5 billion CFU) twice daily, using the same timing principles 4. The evidence in pediatrics shows similar efficacy with manageable adverse effects.
Common Pitfalls to Avoid
Starting too late: The 24-48 hour window is critical. Don't wait for diarrhea to develop—this is prophylaxis, not treatment.
Stopping when antibiotics stop: The additional 7 days post-antibiotic is essential for microbiota recovery 3, 2, 8.
Underdosing: Many studies used 500 mg twice daily (1000 mg/day total). Lower doses may be less effective.
Using in critically ill/immunocompromised patients: Exercise caution with fungemia risk, though S. boulardii has an excellent safety profile in most populations 9.
Contraindications and Safety
S. boulardii is generally well-tolerated. Avoid in:
- Central venous catheter presence (theoretical fungemia risk)
- Severe immunosuppression
- Known hypersensitivity to yeast
Most common adverse effects are mild GI symptoms (nausea, vomiting) 4.